BMS-903452

CAS No. 1339944-47-6

BMS-903452( —— )

Catalog No. M35988 CAS No. 1339944-47-6

BMS-903452 is a potent and selective GPR119 agonist with an EC50 of 14 nM, indicated for the treatment of acute and chronic rodent diabetes.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 234 Get Quote
5MG 366 Get Quote
10MG 520 Get Quote
25MG 756 Get Quote
50MG 1021 Get Quote
100MG 1350 Get Quote
500MG 2646 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    BMS-903452
  • Note
    Research use only, not for human use.
  • Brief Description
    BMS-903452 is a potent and selective GPR119 agonist with an EC50 of 14 nM, indicated for the treatment of acute and chronic rodent diabetes.
  • Description
    BMS-903452 is a potent and selective GPR119 agonist for diabetes research.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    GPR
  • Recptor
    GPR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1339944-47-6
  • Formula Weight
    513.37
  • Molecular Formula
    C21H19Cl2FN4O4S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C1N(C=C(Cl)C(OC2CCN(CC2)C=3N=CC(Cl)=CN3)=C1)C4=C(F)C=C(S(C)(=O)=O)C=C4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Wacker DA, et al. Discovery of 5-chloro-4-((1-(5-chloropyrimidin-2-yl)piperidin-4-yl)oxy)-1-(2-fluoro-4-(methylsulfonyl)phenyl)pyridin-2(1H)-one (BMS-903452), an antidiabetic clinical candidate targeting GPR119. J Med Chem. 2014 Sep 25;57(18):7499-508.?
molnova catalog
related products
  • GPR40/FFAR1 modulato...

    GPR40/FFAR1 modulator 1 is an agonist and an allosteric modulator for Gq-coupled free fatty acid receptor 1 (GPR40/FFAR1).

  • CAY10595

    CAY10595 is an antagonist of the CRTh2 (DP2) receptor with a Ki of 10 nM.

  • Questiomycin A

    Questiomycin A is an antibiotic produced in crème fraiche with antibacterial and anticancer activities. Questiomycin A suppresses expression of GRP78, a cell-protective ER chaperone protein.